Intestinal infection with SARS-CoV-2 has been associated with mild inflammatory response possibly due to the induction of potent neutralizing IgA antibodies which are mainly produced in the intestines [19]; thus, the underlying pathophysiological mechanisms of COVID-19-associated liver dysfunction should further be studied in the context of hepatocyte immune function [10]. This evidence concerns the gene CD79A and digestive system infectious disorder.